REQUEST A DEMO
Total
USD $0.00
Search more companies

E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala (Colombia)

Main Activities: Hospitals
Full name: E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala Profile Updated: November 20, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala is an enterprise located in Colombia, with the main office in Charala. The company operates in the Hospitals industry. E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala was incorporated on December 15, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 30.51% in 2023. Its total assets grew by 10.73% over the same period. The net profit margin of E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala increased by 25.74% in 2023.

Headquarters
Carrera 11 # 25-291
Charala; Santander; Postal Code: 682551

Contact Details: Purchase the E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala report to view the information.

Website: http://www.esehospitalcharala-santander.gov.co

Basic Information
Outstanding Shares:
Purchase the E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala report to view the information.
Incorporation Date:
December 15, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after E.S.E. Hospital Luis Carlos Galan Sarmiento - Charala report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.51%
Total operating revenue
47.94%
Operating profit (EBIT)
6001.56%
EBITDA
409.05%
Net Profit (Loss) for the Period
5140.44%
Total assets
10.73%
Total equity
15.13%
Operating Profit Margin (ROS)
23.97%
Net Profit Margin
25.74%
Return on Equity (ROE)
12.85%
Quick Ratio
165.66%
Cash Ratio
69.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?